Certificates of Analysis
At Axion Peptides, transparency is a requirement, not a feature. Every compound offered on our website is supported by an independent Certificate of Analysis (COA) verifying identity, purity, and batch integrity prior to release.
Each certificate is issued by a third-party analytical laboratory and is matched to a specific production batch. This ensures researchers can independently confirm compound authenticity and eliminate unknown variables in experimental environments.
What our Certificates verify
-
Compound identity through analytical testing
-
Purity percentage for batch consistency
-
Batch-specific results (no reused or generic certificates)
-
Date of analysis to ensure data relevance
-
Third-party laboratory validation
Why this matters
Unverified compounds introduce uncertainty and compromise experimental validity. Our COA process exists to remove ambiguity and provide documented verification before purchase.
If a batch cannot be verified, it is not listed or sold.
Available Certificates
- AOD-9604 – View COA
- TB-500 – View COA
- BPC-157 – View COA
- Tirzepatide 30 mg – View COA
- Tirzepatide 50 mg – View COA
- Retatrutide 10 mg – View COA
- Retatrutide 20 mg – View COA
- HGH – View COA
- GHK-Cu – View COA
Each certificate is provided in PDF or JPEG format and corresponds directly to the listed product batch.
Important notice
All compounds supplied by Axion Peptides are intended strictly for laboratory research use only and are not for human or veterinary consumption.
We strongly encourage all customers to review the relevant Certificate of Analysis prior to ordering.
Transparency Policy
Certificates are published before products go live. If documentation is unavailable or incomplete, the compound is not released.